Literature DB >> 32666178

Multiple endocrine neoplasia type 1 revealed by a hip pathologic fracture.

Maroua Slouma1,2, Maissa Abbes3,4, Rim Dhahri3,4, Noureddine Litaiem4,5, Nour Gueddiche3,4, Nada Mansouri4,6, Issam Msekni4,6, Imen Gharsallah3,4, Leila Metoui3,4, Bassem Louzir3,4.   

Abstract

Multiple endocrine neoplasia type 1 is a rare autosomal inherited syndrome that affects a variety of endocrine tissues such as the parathyroid, endocrine pancreas, and anterior pituitary. Osseous complications are often misdiagnosed. We presented a case of a 46-year-old woman with pathological fractures of the lower limb. She had a history of type 1 diabetes and galactorrhea. Laboratory examinations showed hypercalcemia and an increased level of parathyroid hormone related to hyperparathyroidism. Serum chromogranin A level was increased at 9369 ng/mL (N < 102). A somatostatin receptor scintigraphy (octreoscan) revealed pathological uptake in the gastric wall, later cave adenopathy, and liver. The diagnosis of multiple endocrine neoplasia type 1 was made based on radiological and histological findings. The patient underwent a subtotal parathyroidectomy associated with somatostatin analog treatment leading to significant improvement. A literature review was conducted by searching PubMed using these following terms: multiple endocrine neoplasia type 1, hyperparathyroidism, fracture, menin, osteoporosis. We emphasized bone involvement related to multiple endocrine neoplasia type 1 syndrome. This diagnosis should be considered when pathological fractures occur in young patients with a history of endocrine disorder. We highlighted the importance of imaging features in making the diagnosis of multiple endocrine neoplasia type 1. Early management of this disease is necessary. Treatment including parathyroidectomy and somatostatin analogs leads to bone preservation and functional improvement.

Entities:  

Keywords:  Fracture; Hyperparathyroidism; Menin; Multiple endocrine neoplasia type 1; Osteoporosis

Mesh:

Year:  2020        PMID: 32666178     DOI: 10.1007/s10067-020-05281-3

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  30 in total

1.  Multiple endocrine neoplasia type 1 syndrome: single centre experience from western India.

Authors:  Manjunath Goroshi; Tushar Bandgar; Anurag R Lila; Swati Sachin Jadhav; Shruti Khare; Shailesh V Shrikhande; Shinya Uchino; Abhay N Dalvi; Nalini S Shah
Journal:  Fam Cancer       Date:  2016-10       Impact factor: 2.375

2.  Octreotide as a rapid and effective painkiller for metastatic carcinoid tumor.

Authors:  Miyuki Katai; Akihiro Sakurai; Hidefumi Inaba; Yasuto Ikeo; Keishi Yamauchi; Kiyoshi Hashizume
Journal:  Endocr J       Date:  2005-04       Impact factor: 2.349

3.  Large goiter and multiple rib tumors.

Authors:  M Sato; T Kobayashi; H Dobashi; H Ohye; S Matsubara; K Murao; A Miyauchi; S Kobayashi; J Takahara
Journal:  Endocrine       Date:  2000-02       Impact factor: 3.633

4.  Clinical aspects of hyperparathyroidism in Japanese multiple endocrine neoplasia type 1.

Authors:  M Sato; A Miyauchi; J Takahara
Journal:  Biomed Pharmacother       Date:  2000-06       Impact factor: 6.529

5.  MEN1 disease occurring before 21 years old: a 160-patient cohort study from the Groupe d'étude des Tumeurs Endocrines.

Authors:  P Goudet; A Dalac; M Le Bras; C Cardot-Bauters; P Niccoli; N Lévy-Bohbot; H du Boullay; X Bertagna; P Ruszniewski; F Borson-Chazot; B Vergès; J L Sadoul; F Ménégaux; A Tabarin; J M Kühn; P d'Anella; O Chabre; S Christin-Maitre; G Cadiot; C Binquet; B Delemer
Journal:  J Clin Endocrinol Metab       Date:  2015-01-16       Impact factor: 5.958

6.  Early-onset, progressive, frequent, extensive, and severe bone mineral and renal complications in multiple endocrine neoplasia type 1-associated primary hyperparathyroidism.

Authors:  Delmar M Lourenço; Flavia L Coutinho; Rodrigo A Toledo; Fabio L M Montenegro; Joya E M Correia-Deur; Sergio P A Toledo
Journal:  J Bone Miner Res       Date:  2010-11       Impact factor: 6.741

7.  Multiple endocrine neoplasia type 1 in Brazil: MEN1 founding mutation, clinical features, and bone mineral density profile.

Authors:  D M Lourenço; R A Toledo; I I Mackowiak; F L Coutinho; M G Cavalcanti; J E M Correia-Deur; F Montenegro; S A C Siqueira; L C Margarido; M C Machado; S P A Toledo
Journal:  Eur J Endocrinol       Date:  2008-06-04       Impact factor: 6.664

8.  Prospective study of surgery for primary hyperparathyroidism (HPT) in multiple endocrine neoplasia-type 1 and Zollinger-Ellison syndrome: long-term outcome of a more virulent form of HPT.

Authors:  Jeffrey A Norton; David J Venzon; Marc J Berna; H R Alexander; Douglas L Fraker; Stephen K Libutti; Stephen J Marx; Fathia Gibril; Robert T Jensen
Journal:  Ann Surg       Date:  2008-03       Impact factor: 12.969

9.  Brown tumor of the jaw after pregnancy and lactation in a MEN1 patient.

Authors:  Anna Casteràs; Lídia Darder; Carles Zafon; Juan Antonio Hueto; Margarita Alberola; Enric Caubet; Jordi Mesa
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2016-11-16

10.  Clinical and Genetic Analysis of Multiple Endocrine Neoplasia Type 1-Related Primary Hyperparathyroidism in Chinese.

Authors:  Jing Kong; Ou Wang; Min Nie; Jie Shi; Yingying Hu; Yan Jiang; Mei Li; Weibo Xia; Xunwu Meng; Xiaoping Xing
Journal:  PLoS One       Date:  2016-11-15       Impact factor: 3.240

View more
  2 in total

1.  Hypercalcemia in a patient with a bowing femur.

Authors:  Maroua Slouma; Safa Rahmouni; Rim Dhahri; Maissa Abbes; Imen Gharsallah; Leila Metoui; Bassem Louzir
Journal:  Clin Case Rep       Date:  2020-11-23

Review 2.  A narrative review of multiple endocrine neoplasia syndromes: genetics, clinical features, imaging findings, and diagnosis.

Authors:  Xuefang Hu; Jian Guan; Yangdi Wang; Siya Shi; Chenyu Song; Zi-Ping Li; Shi-Ting Feng; Jie Chen; Yanji Luo
Journal:  Ann Transl Med       Date:  2021-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.